Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |